Even The Economist magazine is writing about weight loss drugs -
https://www.economist.com/the-econo...-the-new-generation-of-weight-loss-drugs-work
"The drugs semaglutide (sold as Wegovy) and tirzepatide (to be sold as Mounjaro) imitate the action of glucagon-like peptide-1 (glp-1), one such hormone. This increases the production of insulin (which transports blood sugar into body cells) and reduces the production of glucagon (which releases sugar into the bloodstream from the liver). It also slows down the rate at which the stomach empties, creating a feeling of fullness that reduces appetite. In addition, the drug may increase energy expenditure by changing fat tissue into brown adipose tissue, which is more likely to be burned at rest. These effects not only help diabetics, but also promote weight loss.
There are drawbacks. Side-effects of glp-1 drugs include nausea and vomiting and there are concerns that they may increase a person’s risk of developing thyroid tumours."
Thyroid problems and weight loss - is it the reason riders were talking to the press about thyroid medication? We must wait and see.